Almost three-quarters of people incarcerated in Irish prisons have some form of substance addiction – but face long waits for ...

Jean-Claude Saghbini is the Chief Technology Officer and President of Lumeris Technology, driving Tom™ – Lumeris' AI-powered Primary Care as a Service platform, delivering scalable, coordinated, and ...

Perceptive Imaging ("Perceptive" or "the Company"), a global leader in clinical trial imaging for the worldwide clinical ...

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced the Company ...

Background Diabetes mellitus (DM) is a common comorbidity in hypertrophic cardiomyopathy (HCM) and may exacerbate arrhythmic ...

Transporeon, a Trimble Company, today announced the launch of its new Transport Planner tool, which delivers optimal ...

High-paying remote finance director jobs often involve managing accounting and financial control functions, establishing ...

Taysha Gene Therapies stock surges after FDA alignment on a pivotal Rett Syndrome study. Read the latest analysis on TSHA ...

Artificial intelligence and analytics platforms seek to help providers improve compliance, patient care experience and ...

Breakthrough Therapy designation granted based on FDA’s review of available clinical evidence of safety and efficacy from all 12 patients treated in Part A of the REVEAL Phase 1/2 trials Finalized FDA ...

Avacta is slated to present the final Phase Ia dose escalation data for our lead program, faridoxorubicin. This will be at ESMO 2025 in Berlin, a little bit later next month in October of 2025. There, ...

A new in-depth report by The Insight Partners highlights Practice Management Systems market growth, driven by need for ...